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Objective: Patients frequently undergo cardiac catheterization before the Fontan operation because of the limited
echocardiographic windows in the region of the superior cavopulmonary connection and branch pulmonary ar-
teries. Patients with obstruction to pulmonary blood flow are at increased risk for prolonged length of hospital stay
after the Fontan operation. Cardiac magnetic resonance has unlimited imaging windows and can quantify both the
branch pulmonary artery size and net flow distribution and thereby serve as a method for identifying patients at
increased risk for prolonged length of stay.
Methods: We retrospectively reviewed 24 cardiac magnetic resonance studies of patients (mean age, 3.1  1.0
years) referred before the Fontan operation. Cardiac magnetic resonance measured the cross-sectional area
and flow to each branch pulmonary artery. Post-Fontan hospital course data were acquired from the medical
record.
Results: Prolonged length of stay after the Fontan operation is observed among patients with one branch that is
less than 25% of the total cross-sectional area (18.0 5.5 vs 8.2 3.8 days, P¼ .01) or with less than 40% flow
to one branch (12.5  6.9 vs 7.6  1.5 days, P ¼ .04). There is moderate correlation between the total branch
pulmonary area and length of stay (r ¼0.75).
Conclusions: Cardiac magnetic resonance noninvasively assesses the branch pulmonary area size and flow be-
fore the Fontan operation. These data predict which patients are more likely to experience a prolonged hospital
course.C
H
DVideo clip is available online.
The Fontan operation completes the process of converting
a patient with a functional single ventricle from a circulation
in parallel to a circulation in series. Investigators studying
predictors of Fontan outcomes have considered the effect
of many factors, including anatomic diagnosis, pulmonary
artery size, ventricular size and function, and the presence
of a reconstructed aortic arch.1-12 Patient characteristics
that had been thought of as high risk for Fontan completion
have been found to produce acceptable intermediate out-
comes in the current era of improved perioperative care.13
However, there are still relatively few and at times conflict-
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Before undergoing the Fontan operation, patients are
commonly assessed with both noninvasive echocardiogra-
phy and invasive diagnostic catheterization, with the occa-
sional need for catheter intervention. Although noninvasive
echocardiographic analysis might be sufficient to determine
which patients will have a good outcome after the Fontan
operation when unlimited echocardiographic windows are
available, frequently the superior cavopulmonary connec-
tion and the branch pulmonary arteries (BPAs) are not ad-
equately assessed.14
Cardiac magnetic resonance (CMR) provides quantitative
measurements of the BPA size and flow distribution,15-17
ventricular ejection,18-20 and cardiac index.21,22 With the ex-
ception of significant coil and stent artifacts, CMR provides
unlimited imaging windows without the use of ionizing ra-
diation. The purpose of this study was to investigate whether
pre-Fontan CMR assessment can predict which patients will
require a longer LoS.
MATERIALS AND METHODS
Patients
Twenty-four consecutive patients were referred for pre-Fontan CMR as-
sessment on clinical grounds between April 2004 and September 2007 and
have undergone Fontan completion. Their demographic data are described
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AVV ¼ atrioventricular valve
AVVR ¼ atrioventricular valve regurgitation
BPA ¼ branch pulmonary artery
CMR ¼ cardiac magnetic resonance
EDV ¼ end-diastolic volume
ESV ¼ end-systolic volume
LoS ¼ length of stay
LPA ¼ left pulmonary artery
LV ¼ left ventricular
RPA ¼ right pulmonary artery
RV ¼ right ventricular
MRI Protocol
CMR studies are monitored by our cardiac anesthesia service. Studies are
conducted while patients are spontaneously breathing. Patients are anesthe-
tized with propofol and generally do not require intubation or paralytics.
The core of the CMR protocol involves assessment of BPA size and flow
distribution, cardiac index, and ventricular size and function. CMR data
were also reviewed for ventricular morphology, atrioventricular valve re-
gurgitation (AVVR), and aortic arch obstruction.
BPA Size and Flow Distribution
The BPAs were measured in 2 orthogonal dimensions, and the cross-sec-
tional area was calculated from the linear measurements. For each BPA, the
smallest cross-sectional area along the segment from the superior cavopul-
monary connection to the origin of the upper lobe branch, including the cen-
tral pulmonary artery portion under the arch, was used for data analysis. By
using phase-contrast magnetic resonance, the fractional BPA pulmonary
blood flow is calculated as follows:
Fractional BPA pulmonary blood flow ¼ ðNet BPA flow=Net total
pulmonary blood flowÞ3100:
The single patient with a BPA endovascular stent was excluded from the
BPA size and flow analysis.
Cardiac Index
Phase-contrast magnetic resonance acquisition was applied at the
aortic valve for flow quantification and was indexed for body surface
area. In patients who have a proximal reconstructive anastomosis of the
great arteries without semilunar valve atresia, separate measurements of
the native aortic and pulmonary valves were performed. The cardiac
index was calculated as the sum of the 2 measurements. Phase-contrast
magnetic resonance data analysis involved contouring regions of interest
throughout all phases of the cardiac cycle. Forward, regurgitant (if app-
licable), and net flows were then automatically calculated from the res-
ulting flow-time curves. The regurgitant fraction through a region of
interest is defined as follows:
Regurgitant fraction ¼ ðReverse flow=Forward flowÞ3 100:
Onepatient,whowoke during the study and could not be resedated, did not
have an aortic phase-contrast magnetic resonance measurement for analysis.
Ventricular Volume Analysis
Cine short-axis imaging of the functional single ventricle was acquired
from the base to the apex of the heart by using 8 contiguous slices ranging
from 6 to 8 mm in thickness, depending on heart size. The ventricular sys-942 The Journal of Thoracic and Cardiovascular Sutolic function analysis involved contouring the blood pool at end-diastole
and end-systole at each level of the volume data set, thereby quantifying
the end-diastolic volume (EDV) and end-systolic volume (ESV). The stroke
volume is defined as the difference between the EDV and ESV, and the ejec-
tion fraction is defined as follows:
Stroke volume=EDV 3 100:
For the purpose of comparison, the patients were grouped into those with
a dominant, functional single right ventricle (Video 1) versus those with
a dominant, functional single left ventricle (Video 2). There were 4 patients
with indeterminate ventricular morphology who were excluded from the
right ventricle versus left ventricle analysis.
Atrioventricular Valve Regurgitation
The atrioventricular valve (AVV) regurgitant fraction was defined by
using the following formula:
AVV regurgitant fraction ð%Þ ¼ ðAVV regurgitant volume per heart beat=
AVV inflow per heart beatÞ3 100
The AVV regurgitant volume is equal to the difference between the
ventricular stroke volume (derived from cine magnetic resonance) and the
cardiac output per heart beat (derived from phase-contrast magnetic reso-
nance). In the absence of semilunar valve regurgitation, the AVV inflow
is equal to the ventricular stroke volume.
TABLE 1. Characteristics of study patients
Parameters Results
Age (y), mean  SD (range) 2.7  0.7 (1.5–5.2)
Male/female sex 13/11
BSA at CMR (m2), mean  SD (range) 0.59  0.05 (0.47–0.67)
Cardiac anomaly (n ¼ 24)
Dominant, functional, single RV n ¼ 13
RV w/Norwood (HLHS, DORV/MA) n ¼ 11 (n ¼ 10, n ¼ 1)
RV w/normal aorta (single RV,
unbalanced CCAVC)
n ¼ 2 (n ¼ 1, n ¼ 1)
Dominant, functional, single LV n ¼ 7
LV w/Norwood (DILV/TGA) n ¼ 1
LV w/normal aorta
(TA, DILV/TGA {S,L,L})
n ¼ 6 (n ¼ 5, n ¼ 1)
Indeterminate ventricular morphology n ¼ 4
SCPC (n ¼ 24)
Age (y), mean  SD [range] 0.5  0.1 [0.3–0.7]
BDG (right bilateral) n ¼ 18 (n ¼ 15, n ¼ 3)
Hemi-Fontan n ¼ 6
Fontan (n ¼ 24)
Age (y), mean  SD (range) 3.1  1.0 (2–7.5)
Extracardiac conduit n ¼ 18
Lateral tunnel n ¼ 6
Fenestrations n ¼ 23
SD, Standard deviation; BSA, body surface area; CMR, cardiac magnetic resonance;
RV, right ventricle;HLHS, hypoplastic left heart syndrome;DORV, double-outlet right
ventricle; MA, mitral atresia; CCAVC, complete common atrioventricular canal; LV,
left ventricle;DILV, double-inlet left ventricle; TGA, transposition of the great arteries;
TA, tricuspid atresia; TGA(S,L,L), situs solitus of the atria with right ventricular outlet
chamber to the left of the dominant morphologic left ventricle, aorta (arising from the
right ventricular outlet chamber) to the left of the pulmonary artery (arising from the
dominant left ventricle); SCPC, superior cavopulmonary connection; BDG, bidirec-
tional Glenn; Hemi-Fontan, patch closure of the superior vena cava–right atrial junc-
tion and side-to-side anastomosis of the superior vena cava–right pulmonary artery
junction.rgery c October 2009
Harris et al Congenital Heart DiseaseFIGURE1. Comparison of hospital length of stay for patients with differential size and flow characteristics. Patients with one branch pulmonary artery (BPA)
that had an area of less than 25% of the total cross-sectional area (CSA) were compared with patients with BPAs that both had areas greater than 25% of the
total CSA. Patients with one BPA that received less than 40% of the total flowwere compared with patients with BPAs that both received greater than 40% of
the flow. Both comparisons show a significant difference. Error bars depict the standard deviation.C
H
DAortic Arch Obstruction
Aortic arch adequacy was determined by means of direct measure-
ment with gadolinium magnetic resonance angiographic analysis (n ¼
22) and bright-blood static axial images (n ¼ 24). In circumstances in
which there was clinical concern for residual aortic arch obstruction,
such as Norwood reconstruction, off-axis cine imaging of the aortic
arch was used for further delineating arch morphology and identifying
flow turbulence (Videos 3 and 4).
Pre-Fontan Echocardiographic Analysis and
Catheterizations
Pre-Fontan echocardiograms and, where available, cardiac catheteriza-
tions were reviewed for assessment of the superior cavopulmonary connec-
tion and BPA anatomy, ventricular function, AVVR, and aortic arch
obstruction.
Hospital Course
The medical record was reviewed for determination of the surgical pro-
cedure, complications, and LoS. The LoS was defined as days of hospital-
ization within the first 30 days after the Fontan operation.23 There were 2
patients who were discharged and subsequently readmitted for treatment
of infection. One patient had an isolated wound infection, and the other pre-
sented with mediastinitis (fever, wound degeneration, and an associated
effusion) and required a prolonged readmission because of parental
noncompliance with antibiotic treatment. For both patients, their LoSs
was calculated on the basis of their initial hospitalization.
Statistical Analysis
Standard descriptive statistics using means with ranges and standard
deviations were used to describe the patient demographics. The 2-tailed,
2-sample Student’s t test was used to compare the LoS, cardiac index,
percentage left pulmonary artery (LPA) size, and percentage LPA flow
data between patient groups dichotomized by ventricular morphology and
the presence of Norwood reconstruction. Patients were also dichotomized
by percentage size and flow to one branch of the pulmonary artery, and
the 2-tailed, 2-sample Student’s t test was used to compare differences in
LoS. A power regression was used to examine the relationship between
the total indexed BPA size and the LoS. All statistical analysis was
performed with Microsoft Excel software (Microsoft, Redmond, Wash).
The authors had full access to the data and take responsibility for its in-
tegrity. All authors have read and agree to the article as written. The study
was approved by the Institutional Review Committee of The Children’s
Hospital of Philadelphia.The Journal of Thoracic and CRESULTS
Hospital Course
All 24 patients underwent the Fontan operation. There
were no deaths. The mean LoS was 10 days, the median
was 8 days, the mode was 5 days, and the range was 4 to
25 days. In 22 of the 24 patients, the primary postoperative
issue specifically noted in the medical record was diuretic
therapy for pleural effusions, which accounted for the
LoS. The mean discharge oxygen saturation for all patients
was 86.4%  3.4%, with a range of 77% to 94%. There
was 1 patient with cyanosis caused by arteriovenous malfor-
mations and 1 patient with a moderate pericardial effusion.
BPA Size/Flow Distribution and LoS
The mean right pulmonary artery (RPA) cross-sectional
area measured 1.0  0.4 cm2/m2, and the mean LPA
cross-sectional area measured 0.6  0.3 cm2/m2. The
mean RPA versus LPA flow distribution measured 59.6%
versus 41.4%  19.6%.
Patients were dichotomized by differential BPA size and
flow. Patients with one BPA accounting for less than 25% of
the total cross-sectional area, patients with one BPA ac-
counting for less than 40% of the total net BPA flow, or
both remained in the hospital significantly longer (Figure 1).
There was moderate correlation between the total (RPA plus
LPA) cross-sectional area and LoS. Patients with a total
cross-sectional area of less than 1.5 cm2 experienced a non-
linear increase in LoS (Figure 2).
LoS, Cardiac Index, Percentage LPA Size, and
Percentage LPA Flow
When dichotomized by ventricular morphology, it was
found that patients with the dominant ventricle having
left ventricular (LV) morphology had a shorter LoS and
higher cardiac index compared with patients with dominant
ventricles of right ventricular (RV) morphology. There was




Congenital Heart Disease Harris et alflow between LV and RV morphologies. When dicho-
tomized by the presence of Norwood reconstruction, pa-
tients without Norwood reconstructions had a shorter
LoS. However, there was no significant difference in car-
diac index, percentage LPA size, or percentage LPA
flow (Figure 3).
Ventricular Volume Analysis
Volume data from cine magnetic resonance demonstrated
that patients with RV and LV morphologies had no signifi-
cant differences in EDV. However, stroke volume and ejec-
tion fraction were higher in patients with LV morphology,
which was associated with a significantly smaller LV ESV
FIGURE 2. Power regression comparing the total cross-sectional area of
the right pulmonary artery (RPA) and left pulmonary artery (LPA) with
length of stay (LoS). Note that at less than 1.5 cm2, the LoS increases in
a nonlinear fashion.944 The Journal of Thoracic and Cardiovascular Surcompared with RV ESV. No significant differences in
EDV, ESV, or stroke volume were found when comparing
patients with Norwood reconstructions with patients with
normal aortas. The difference in ejection fraction reached
significance when the data were analyzed according to
whether a patient had a Norwood reconstruction versus
a normal aorta. (Figure 4).
AVVR and Aortic Arch Assessment
Ventricular stroke volume data (from cine magnetic reso-
nance) and aortic valve flow data (from phase-contrast mag-
netic resonance) were available in 19 patients for
quantification of AVVR. Seventeen (89%) of 19 patients
had AVV regurgitant fractions of less than 10%. Two
(11%) of 19 patients had an AVV regurgitant fraction of be-
tween 10% and 21%. The CMR aortic arch assessment in
all patients did not reveal any significant coarctation thought
to require further intervention.
Pre-Fontan Echocardiographic Data
In 10 (42%) of the 24 patients, echocardiographic analy-
sis correctly identified that the superior cavopulmonary con-
nection and the BPAs were unobstructed. Because of limited
echocardiographic windows, the superior cavopulmonary
connection and at least one of the BPAs could not be ade-
quately assessed in 6 and 12 patients, respectively. In one in-
stance the limitation of echocardiography was attributed to
the patient being nonsedated, and a second patient could
not be properly assessed because of an artifact produced
by a pulmonary artery stent.FIGURE 3. Comparison of hospital length of stay, cardiac index, left pulmonary artery area divided by total cross-sectional area (% LPA Size), and left
pulmonary artery flow divided by total flow (% LPA Flow) for different patient groups. Patients with right ventricular morphology (RV) were compared
with patients with left ventricular morphology (LV), and patients who underwent Norwood reconstructions were compared with patients with normal aortas.
P values are shown for each comparison. NS, Nonsignificant P values. Error bars depict the standard deviation.gery c October 2009
Harris et al Congenital Heart DiseaseFIGURE 4. Comparison of volumetric data between patients with right ventricular morphology (RV) and patients with left ventricular morphology (LV) and
between patients who underwent Norwood reconstructions and patients with normal aortas. P values are shown for each comparison. NS, Nonsignificant
P values. Error bars depict the standard deviation.C
H
DCatheterization Data
There were 12 Pre-Fontan cardiac catheterizations. Of the
12 Pre-Fontan catheterizations, 3 were interventional. All 3
interventions were balloon angioplasty of one of the BPAs.
Two of the interventional catheterizations were performed
before CMR, and one was performed after CMR demon-
strated RPA stenosis. Nine of the 12 catheterizations were
diagnostic and did not alter the patient’s clinical course.
No patient who underwent catheterization after CMR had
new findings that led to a catheter intervention or an altered
surgical approach.
There was one diagnostic catheterization performed in the
immediate post-Fontan period (postoperative day 7) for de-
termination of the cause of cyanosis. The patient was known
to have arteriovenous malformations diagnosed by means of
preoperative catheterization. No new diagnostic data were
derived, and no intervention was performed. The patient
was discharged on postoperative day 12.
DISCUSSION
In the present study we found that CMR measurements of
the BPA sizes and flows are predictive of a patient’s LoS af-
ter the Fontan operation. We demonstrate that small BPAs
with a significant differential in size or flow distribution
are associated with a prolonged LoS. Many studies have
concentrated on the effect of small BPAs on Fontan opera-
tion–related mortality.1-7,12,13 It has been shown that even
patients thought to have a contraindication to the Fontan
operation because of small BPAs can safely undergo the
procedure.4,13
Our investigation of BPAs is unique in several ways.
First, using precise CMR measurements from tomographicThe Journal of Thoracic and Cimages (rather than cardiac catheterization angiographic
projection images), our analysis, as presented in Figure 1,
emphasizes differential size (and flow) between the 2 lungs
rather than absolute cross-sectional area. Our data suggest
that the differences in cross-sectional area (and pulmonary
blood flow) between the 2 lungs might be as important as
the total available pulmonary vascular tree. This finding is
consistent with the fact that although patients with a single
lung can survive the Fontan operation, they are at increased
risk for morbidity and mortality.24
Second, by using phase-contrast magnetic resonance, this
is the first study to demonstrate the effect of BPA differential
flow on LoS. Investigating differential flows is important be-
cause BPAsmight appear to be of normal caliber without ste-
nosis but still have a significantly altered flow distribution.
Finally, in Figure 2 we display the value of correlating to-
tal cross-sectional area with LoS. This power regression
demonstrates that at approximately 1.5 cm2, the LoS in-
creases in a nonlinear fashion. This critical value has never
been reported in the Fontan literature.
Moreover, this is the first study to use CMR for measuring
ventricular size, function, and cardiac index in patients un-
dergoing the Fontan operation. When indexed for body sur-
face area, our cine data suggest that dominant ventricles with
either RV or LV morphologies have similar EDVs. How-
ever, the RV ESV is significantly greater than the LV
ESV, resulting in a relatively lower RV stroke volume and
RV ejection fraction. Phase-contrast magnetic resonance
measurement of the cardiac index confirms the cine data,
showing that the cardiac index in patients with RVmorphol-
ogy was significantly lower than that seen in patients with




Congenital Heart Disease Harris et alpatients with RV morphology had a prolonged LoS after the
Fontan operation compared with that seen in patients with
LV morphology (12.7 vs 5.3 days, P< .01). Quantification
of ventricular function is especially important to measure in
light of the recent report of Hosein and colleagues,12 which
argued that preoperative ventricular function is predictive of
early and late Fontan outcome. Furthermore, we did not find
significant differences in pulmonary artery size or flow
among patients with RV and LV morphologies as a means
of explaining their differences in LoS. Rather, these differ-
ences appear to be associated with ventricular function and
cardiac index. Although patients with a Norwood recon-
struction had a prolonged LoS (12.4 vs 7.7 days, P ¼ .05),
there were no differences in percentage LPA size, percent-
age LPA flow, EDV, ESV, or cardiac index to explain this
finding.
Future Directions
It has been argued that in the context of excellent imaging
windows, noninvasive echocardiographic analysis can be
used reliably to determine whether a patient can safely un-
dergo the Fontan operation without confirmation with diag-
nostic cardiac catheterization.14 However, frequently
echocardiographic windows are limited and the imaging
data are inadequate for assessment of the superior cavopul-
monary connection and BPAs. Therefore many patients
would require diagnostic pre-Fontan catheterization based
on echocardiographic data alone.
In this retrospective study we demonstrate the broad ca-
pacity of CMR to assess patients before the Fontan opera-
tion. CMR can quantify BPA size/flow, ventricular
function, cardiac index, AVVR, and residual coarctation.
We include a subpopulation analysis of the available echo-
cardiographic and catheterization data. In half of our pa-
tients, at least one of the BPAs could not be adequately
assessed echocardiographically. Furthermore, of the 12
pre-Fontan catheterizations, 9 were diagnostic, and none
had new findings that led to a catheter intervention or an al-
tered surgical approach. Of note, there was one patient in
whom CMR identified RPA stenosis, which led to interven-
tional balloon angioplasty.
Currently, diagnostic catheterization remains the standard
of care among many pediatric cardiologists for pre-Fontan
assessment.25 There is clearly a need for physicians taking
care of these complex patients to develop a methodology to-
ward standardizing pre-Fontan assessment. This is an imper-
ative issue to address in light of recent studies demonstrating
that children exposed to ionizing radiation from diagnostic
imaging are at increased risk of future malignancies.26,27
Given our experience that most pre-Fontan catheterizations
are purely diagnostic in nature, it is logical that, where avail-
able, CMR should ideally serve as the initial screening tool
for pre-Fontan assessment and as the basis for referring
patients for interventional catheterization. Therefore we946 The Journal of Thoracic and Cardiovascular Suradvocate for a larger prospective study to determine whether
CMR can replace routine invasive diagnostic catheterization
for pre-Fontan assessment.
Study Limitations
The major limitation of this study is its retrospective na-
ture. A prospective study in which all patients undergo
both CMR and catheterization is necessary to more com-
pletely compare the efficacy and safety of CMR versus diag-
nostic catheterization. In contrast to other post-Fontan
outcome studies, this study population is fairly uniform
and represents pre-Fontan patients who have all been as-
sessed in the current surgical era at a single center. The
only major exception to this with respect to surgical tech-
nique is that 25% of the patients underwent a lateral tunnel
instead of an extracardiac conduit Fontan operation. The RV
versus LVmorphology volume and function data are limited
by the relatively small sample sizes and the fact that these
comparisons were univariate analyses. Further investigation
is warranted to confirm these suggested findings. Finally, the
subpopulation analysis comparing CMR and catheterization
might be limited because it is possible that other institutions
have different pre-Fontan interventional catheter strategies,
resulting in more referrals to interventional catheterization
and less purely diagnostic catheterizations.
CONCLUSION
In conclusion, quantitative CMR measurements of BPA
size and flow in pre-Fontan patients predict LoS after the
Fontan operation. CMR suggests that pre-Fontan patients
with a dominant ventricle of RV morphology have lower
ejection fractions and cardiac indexes compared with pa-
tients with LV morphology. Finally, CMR is an excellent
imaging tool for assessment of the cavopulmonary connec-
tion and BPAs in patients undergoing the Fontan operation.
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